China SXT Pharmaceuticals Inc (SXTC) — Free Cash Flow Generation Index
China SXT Pharmaceuticals Inc (SXTC) has a Free Cash Flow Generation Index of 0.89x as of December 2022. Free cash flow of $208.90K represents 1% of operating cash flow ($234.18K). See SXTC current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China SXT Pharmaceuticals Inc Free Cash Flow Generation Index (2016–2022)
Historical FCF Generation Index trend for China SXT Pharmaceuticals Inc across 6 annual periods. Explore debt repayment capacity of China SXT Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for China SXT Pharmaceuticals Inc (2016–2022)
Year-by-year Free Cash Flow Generation Index for China SXT Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of China SXT Pharmaceuticals Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.77x | $205.80K | $268.29K | $62.49K | ▲ +35.8% |
| 2020 | 0.56x | $527.59K | $934.25K | $406.66K | ▲ +136.4% |
| 2019 | -1.55x | $-370.89K | $239.19K | $610.09K | ▼ -442.5% |
| 2018 | 0.45x | $869.44K | $1.92 Million | $1.05 Million | ▲ +24.3% |
| 2017 | 0.36x | $106.73K | $293.04K | $186.31K | ▼ -22.3% |
| 2016 | 0.47x | $85.48K | $182.47K | $96.99K | — |